- Home
- NAGE vs RNAC Comparison
NAGE vs RNAC Comparison
Compare NAGE & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAGE | RNAC |
|---|---|---|
| Founded | 1999 | 2007 |
| Country | United States | United States |
| Employees | 117 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 261.2M | 238.9M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | NAGE | RNAC |
|---|---|---|
| Price | $3.03 | $8.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $16.00 | ★ $34.00 |
| AVG Volume (30 Days) | ★ 782.7K | 124.2K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,797,000.00 |
| Revenue This Year | $16.51 | N/A |
| Revenue Next Year | $14.58 | N/A |
| P/E Ratio | $21.29 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.87 | $5.60 |
| 52 Week High | $10.52 | $12.23 |
Technical Indicators
Market Signals| Indicator | NAGE | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 40.71 | 55.29 |
| Support Level | N/A | $5.89 |
| Resistance Level | $3.60 | $9.27 |
| Average True Range (ATR) | 0.16 | 0.45 |
| MACD | -0.02 | 0.11 |
| Stochastic Oscillator | 21.19 | 85.71 |
Price Performance
Historical ComparisonAbout NAGE Niagen Bioscience Inc.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.